Back

Cardiac in vivo correction of the PLN R14del cardiomyopathy mutation using prime editing

29 August 2026 (10:57 - 11:09)
Organised by: Logo
Congress Presentation Part of: Translational, genetic, and precision medicine approaches Gene Therapy, Cell Therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Vijayanand Rajendran

TUM Klinikum Rechts der Isar, Munich (Germany)

4 More presentations in this session

Presentation thumbnail
Functional characterisation of AI-prioritised sarcomeric variants in hypertrophic cardiomyopathy using iPSC-derived cardiomyocytes
Doctor I. Balakrishnan (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
A novel serum biomarker molecule for heart failure progression： VDAC3 protects against heart failure by aediating SLC25A11 stability and repairing ATP synthesis
Professor C. Yan (CN)
Abstract Slides Video
Presentation thumbnail
A DNA damage checkpoint drives phenotypic transition in cardiomyopathy
Doctor J. Komuro (Frankfurt, DE)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes in a large-scale ventricular septal defect cohort: impact of anatomical subtype and intervention timing
Doctor S. Goo (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Translational, genetic, and precision medicine approaches
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 10:57 CET
You may be interested in
thumbnail
Congress Session
Gene editing and gene therapies to cure cardiovascular diseases
31 August 2024
thumbnail
Congress Presentation
Prime editing correction of an Nkx2-5 variant in a murine congenital heart disease model
1 September 2025
thumbnail
Congress Presentation
Next-generation cardiomyopathy models: CRISPR/Cas9-edited pigs for personalized cardiac therapeutics
1 September 2025
thumbnail
Congress Presentation
AAV-mediated gene therapy improves cardiac function in humanized PLN-R14del mice: a preclinical model of PLN-R14del induced cardiomyopathy
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources